• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Mechanism of pathological aging of brain by using transgenic mice

Research Project

Project/Area Number 10832002
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 老化(加齢)
Research InstitutionGunma University

Principal Investigator

HARIGAYA Yasuo  Gunma University School of Medicine Assistant Professor, 医学部, 講師 (90165035)

Co-Investigator(Kenkyū-buntansha) SHOJI Mikio  Gunma University School of Medicine Assistant Professor, 医学部, 講師 (60171021)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 1999: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1998: ¥2,300,000 (Direct Cost: ¥2,300,000)
KeywordsALZheimer's disease / Transgenic mice / Amyloid β protein / apolipoprotein E / 血液Aβ / アポリポ蛋白E / 老人斑
Research Abstract

We first examined transgenic mice (Tg) expressing human βAPP695 ΔNL (APPsw mice : Hsiao K et al. Science 1996) to clarify the character of amyloid β protein (Aβ) deposited in brains of these mice. In 8-month-old mice, giant cored plaques (CP) appeared in the hippocampus and the cerebral cortex. Diffuse plaques (DP) and amyloid angiopathy (AA) in some small vessels of cerebral cortex and subaracnoidal space were recognized in 12-month-old mice, and increased with age. These neuropathological structures consisted of various Aβ species with both N-and C- terminal modifications such as those of AD brains. Accumulation of hyperphosphorylated tau as well as _βAPP were observed in dystrophic neurites surrounding CP. Neuronal cell loss as well as synaptic loss were found in cored plaques. The substantial amounts of Aβ40 and Aβ42 in brains at the age of 8 months were detected, and remarkably increased with the evolution of Aβ amyloidosis. Passive avoidance test revealed that these mice have significant memory impairment at the age of 8.5 months. Thus, APPsw mice are useful models for examining the mechanism of AD pathology.
Next, to clarify whether Apolipoprotein E(ApoE) promotes deposition of Aβ in vivo, we examined both brains and plasma of Tg that coexpress APPsw and rat Apo E (corresponding to human ApoE4)((βAPP(+)ApoE(+) Tg). There were no differences in the degree of CP, DP, and AA of between βAPP(+)ApoE(+) Tg and βAPP(+)ApoE(-) Tg at the age of 4 and 8 months. However, at the age of 12 months, degree of CP, DP, and AA in βAPP(+)ApoE(+) Tg was greater than those of βAPP(+)ApoE(-) Tg. The levels of both Aβ40 and Aβ42 in brains of βAPP(+)ApoE(+) Tg were higher than those of βAPP(+)ApoE(-) Tg by 12% and 60%, respectively. Furthermore, the levels of Aβ40 in plasma of βAPP(+)ApoE(+) Tg were also higher than those of βAPP(+)ApoE(-) Tg by 40%. Thus, those findings suggest that ApoE accelerates Aβ deposition by increasing Aβ concentration.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (42 results)

All Other

All Publications (42 results)

  • [Publications] Matsubara E.,Harigaya Y.et al.: "Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome"Annals of Neurology. 45. 537-541 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tomidokoro Y.,Harigaya Y.et al.: "Carboxyl-terminal fragments of preserilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains"Biochem. Biophys. Res. Commun.. 256. 512-518 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanai M.,Harigaya Y.et al.: "Apolipoprotein E4 accelerates dementia and increases cerebrospinal tau levels in Alzeimer's disease"Neurosci. Lett.. 267. 65-68 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shoji M.,Harigaya Y.et al.: "Distribution of amyloid β protein precursor in the Alzheimer's disease brain"Phychiatry and Clinical neurosciences. 54. 45-54 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ikeda Y.,Shoji M.et al.: "Molecular and clinical analysis of spinocerebellar ataxia type8 in Japan"Neurology. 54. 950-955 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Urakami K.,Shoji M.et al.: "A comparison of tau protein in cerebrospinal fluid between corticohusal degeneration and progressive supranuclear palsy"Neurosci. Lett.. 259. 127-129 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 東海林幹夫: "アルツハイマー病の新しい展開"羊土社. 170 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 東海林幹夫: "老年期痴呆診療マニュアル(第2版)"日本医師会/南江堂. 341 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shoji M, Harigaya Y, et al.: "Age-related amyloid β protein accumulation induces cellular death and macrophage activation in transgenic mice."J Pathol. (in Press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shoji M, Harigaya Y, et al.: "Accumulation of NACP/α-synuclein in Lewy body disease and multiple system atrophy."J Neurol Neurosurg Psychiatry. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shoji M, Harigaya Y, et al.: "The distribution of the amyloid β protein precursor in the Alzheimer's disease brain."Psychiat Clin Neurosci. 54. 45-54 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsubara E, Harigaya Y, Shoji M, et al.: "Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome."Ann Neurol. 45. 537-41 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tomidokoro Y, Harigaya Y, Shoji M, et al.: "Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains."Biochem Biophys Res Commun. 256. 512-8 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanai M, Harigaya Y, Shoji M, et al.: "Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease."Neurosci Lett. 267. 65-8 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ikeda Y, Shoji M, et al.: "Molecular and clinical analysis of spinocerebellar ataxia type 8 in Japan."Neurology. 54. 950-55 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hu J, Shoji M, et al.: "Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population."Neurosci Lett. 277. 65-7 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Lin C, Shoji M, et al.: "Deletion and nonsense mutations of the connexin 32 gene associated with Charcot-Marie-Tooth disease."Tohoku J Exp Med. 188. 239-44 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shizuka M, Shoji M, et al.: "A novel mutation of the myelin P(o) gene segregating Charcot-Marie-Tooth disease type 1B manifesting as trigeminal nerve thickening."J Neurol Neurosurg Psychiatry. 67. 250-1 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mizushima K, Shoji M, et al.: "Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis : (CCG)1-2 polymorphism and contribution to founder effect."J Med Genet. 36. 112-4 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Urakami K, Shoji M, et al.: "A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy."Neurosci Lett. 259. 127-9 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shoji M, Harigaya Y: "Biochemical heterogeneity of Alzheimer's disease."Neuropathology. 18. 116-120 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shoji M, Harigaya Y, et al.: "Combination assay of CSF tau, Aβ 1-40 and Aβ 1-42(43) as a biochemical marker of Alzheimer's disease."J Neurol Sci. 158. 134-40 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shoji M, Harigaya Y, et al.: "Accumulation of amyloid beta protein in transgenic mice."Neurobiol Aging. 19. S59-63 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanai M, Harigaya Y, Shoji M, et al.: "Longitudinal study of cerebrospinal fluid levels of tau, Aβ 1-40, and Aβ 1-42(43) in Alzheimer's disease : a study in Japan."Ann Neurol. 44. 17-26 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shizuka M, Shoji M, et al.: "Molecular analysis of a de novo mutation for spinocerebellar ataxia type 6 and (CAG)n repeat units in normal elder controls."J Neurol Sci. 161. 85-7 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Watanabe M, Shoji M, et al.: "Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein."Ann Neurol. 44. 265-9 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsubara E,Harigaya Y,et al: "Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome"Annals of Neurology. 45. 537-541 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tomidokoro Y,Harigaya Y,et al: "Carboxyl-terminal fragments'of presenilin-1 are dosely related to cytoskeletal abnormalities in Alzheimer's brains"Biochem Biophys Res Commum. 256. 512-518 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kanai M,Harigaya Y,et al: "Apolipoprotein E4 accelerates dementia and increases cerebrospinal tau levels in Alzheimer's disease"Neurosci Lett.. 267. 65-68 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Shoji M,Harigaya Y,et al: "Distribution of amyloid βprotein precursor in the Alzheimer's disease brain"Psychiatry and Clinical neurosciences. 54. 45-54 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ikeda Y,Shouji M,et al: "Molecular and clinical analysis of spinocerebellar ataxia type 8 in Japan"Neurology. 54. 950-955 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Urakami K,Shouji M,et al: "A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive suprany-dearpasy"Neurosci Lett. 259. 127-129 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 東海林幹夫: "アルツハイマー病の新しい展開"羊土社. 170 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 東海林幹夫: "老年期痴呆診療マニュアル(第2版)"日本医師会/南江堂. 341 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Shoji M,Harigaya Y et al.: "Combination assay of CSF tau,Aβ_<1-40> and Aβ_<1-42(43)> as a biochemical marker of Alzheimer's disease." J Neurol Sci. 158. 134-140 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Shoji M,Harigaya Y: "Biochemical heterogeneity of Alzheimer's disease" Neuropathology. 18. 116-120 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Shoji M,Harigaya Y et al.: "Accumulation of amyloid β protein transgenic mice." Neurobiol Aging. 19. S59-63 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Matsubara E,Shoji M,Harigaya Y.: "Lipoprotein-free amyloidogenic pentides in plasma are elevated in the patients with sporadic Alzheimer's diseace and Down's syndrome" Ann Neurol. in press. (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tomidokoro Y.Harigaya Y.: "Carboxylterminal fragments' of presenilin-lare closely relatea Metal to cytoskeletal abnormality in Alzheimer's brains." Biochem Biophys Res Commun. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kanai M,Harigaya Y,Shoji M.et al.: "Longitudinal study of cerebrospinal fluid levels of Tau,Aβ_<1-40> and Aβ_<1-42(43)> in Alzheimer's dicease:A Study in Japan" Ann Neurol. 44. 17-26 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 東海林幹夫: "アルツハイマー病の病理と成因.平井俊策編.老化の仕組みと疾患" 羊土社, 7 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 東海林幹夫: "アルツハイマー病の動物モデル-解明点と問題点.井原康夫編 新臨床医のための分子医学シリーズ" 羊土社, (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi